Impel Pharmaceuticals Inc. is a biopharmaceutical company based in Seattle, Washington, focused on developing innovative therapies for patients with central nervous system disorders. The company specializes in drug delivery technologies, particularly its proprietary intranasal delivery system, which aims to enhance the efficacy and convenience of medications. By leveraging advanced formulation and delivery methods, Impel seeks to address unmet medical needs and improve treatment outcomes for various neurological conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

10 Patents

#201 in Seattle, WA

#685 in Washington

#29,866 in US

#56,047 in the World

Seattle, WA, United States of America

Impel Pharmaceuticals Inc.

Forward Citations = 1

14 inventors:

John D Hoekman (7 out of 21 patents)

Craig Frederick Kohring (5 out of 8 patents)

Christopher William Fuller (5 out of 9 patents)

4. Kelsey H Satterly (3 out of 5 patents)

5. Inna Dashevsky (3 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Impel Pharmaceuticals Inc.. Retrieved from https://idiyas.com/company/impel-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]